首页> 外文期刊>臨床血液 >Hypereosinophilic syndrome developing after prednisolone therapy for autoimmune hemolytic anemia
【24h】

Hypereosinophilic syndrome developing after prednisolone therapy for autoimmune hemolytic anemia

机译:对自身免疫性溶血性贫血的泼尼松酮治疗后的过度粒细胞综合征

获取原文
获取原文并翻译 | 示例
       

摘要

A 26-year-old woman was diagnosed as having autoimmune hemolytic anemia in September 2002. Her eosinophil count was already high (2,190/microliter) at that time. She received prednisolone therapy with a good response and was released from the treatment in April 2003. Eosinophil numbers were within the normal range under the prednisolone administration. However, they began to increase after its completion. No underlying causes for the eosinophilia were evident. When the eosinophil count reached 5,474/microliter, the patient developed massive pleural effusion as well as palpebral swelling and myalgia, leading to a diagnosis of hypereosinophilic syndrome. Re-administration of prednisolone resulted in the disappearance of these symptoms and eosinophilia. Her eosinophils seemed to have reactivated after cessation of the prednisolone therapy and infiltrated into her organs.
机译:2002年9月,一名26岁的女性被诊断为具有自身免疫性溶血性贫血。当时,她的嗜酸性粒细胞计数已经很高(2,190 / micro)。 她接受了泼尼松龙治疗,良好的反应,并于2003年4月从治疗中释放。嗜酸性粒细胞数在泼尼松酮给药下的正常范围内。 但是,完成后他们开始增加。 没有嗜酸性粒细胞的根本原因是显而易见的。 当嗜酸性粒细胞计数达到5,474 /微升时,患者发育了巨大的胸腔积液以及睑肿胀和肌痛,导致过嗜酸性综合征的诊断。 重新施用泼尼松导致这些症状和嗜酸性粒细胞的消失。 她的嗜酸性粒细胞似乎在停止泼尼松治疗后重新激活并渗透到她的器官中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号